Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sun Pharmaceutical Industries Ltd. Capital/Financing Update 2021

Sep 1, 2021

59215_rns_2021-09-01_354a8332-533c-4702-9b06-75159ad06056.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Sun Pharmaceutical Industries Ltd. Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai - 400 063, Maharashtra, INDIA. Tel. : (91-22) 4324 4324 Fax : (91 -22) 4324 4343 Website : www.sunpharma.com CIN : l24230GJ1993PLC01 9050

September 1, 2021

National Stock Exchange of India Ltd., Exchange Plaza, 5th Floor, Plot No. C/l, G Block, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051 . NSE Code: SUNPHARMA

BSE Limited, Market Operations Dept. P. J. Towers, Dalal Street, Mumbai - 400 001 . Stock Code: 524715

Subject: Disclosure under Regulation 30 read with Schedule ID of SEBI (Listing Obligation and Disclosures Requirements) Regulations, 2015, as amended ("Listing Regulations") read with Securities and Exchange Board of India circular no. CIR/CFD/CMD/4/2015 dated September 9, 2015 ("SEBI Circular").

Dear Sirs,

Pursuant to the requirements under Regulation 30 of the Listing Regulations, we would like to inform about the sale of Kayaku Co. Ltd, a wholly-owned subsidiary of Sun Pharma Japan Limited ("Sun Pharma Japan"), a step-down subsidiary of the Company. Sun Pharma Japan sold its entire shareholding in Kayaku Co. Ltd. to Shinshin Pharmaceutical Co., Ltd. ("buyer") on pt September 2021 for a total consideration of JPY 353,983 ,400. Thus Kayaku Co. Ltd has ceased to be the subsidiary of the Company w.e.f. today.

Shinshin Pharmaceutical Co. Ltd., is a Japan-based pharmaceutical company with its office at 324 lmaich, Toyama City, Toyama 930-2224 Japan. The buyer does not belong to the promoter/promoter group/group companies, and the transaction does not fall within the purview of Related Party Transactions.

The subsidiary company, Kayaku Co. Ltd whose entire shareholding is sold to the buyer comprised a factory at Tokorozawa and its related assets and liabilities. It is engaged in the business of manufacturing pharmaceutical products for external pharmaceutical companies.

The other business of Kayaku Co. Ltd comprising the Saitama Factory and products manufactured thereat were carved out of Kayaku Co. Ltd with effect from P1 September, 2021 and transferred to Sun Pharma Japan Technical Operations Limited, a new subsidiary of Sun Pharma Japan set up for the purpose.

Page 1of2

Sun Pharmaceutical Industries Ltd.

Sun House, Plot No. 201 B/1, Western Express Highway, Goregaon (E), Mumbai - 400 063, Maharashtra, INDIA. Tel. : (91-22) 4324 4324 Fax : (91-22) 4324 4343 Website: www.sunpharma.com GIN : l24230GJ1993PLC019050

The turnover and net worth contributed by Kayaku Co. Ltd, to the extent of Tokorozawa Factory and products manufactured thereat, during the last financial year i.e. FY 20-21 was about JPY 1,933 million and about JPY 1,650 million respectively, which translates to less than 0.5% of the consolidated turnover and consolidated net worth of the Company respectively.

Thanking you, Yours faithfully, For Sun Pharmaceutical Industries Limited

A~ Bhuta)

(Ashok Sr. GM - Secretarial & Compliance Officer